Search Login Register
zafirlukast
(Accolate)
Summary
Description:
a leukotriene D4 receptor antagonist
Also Known As:
Accolate; 4-(5-cyclopentyloxycarbonylamino-2-methylindol-3-yl-methyl)-3-methoxy-N-O-tolylsulfonylbenzamide; Aeronix; AstraZeneca brand of zafirlukast; ICI 204,219 Show All >>
Networked: 229
relevant articles (52 outcomes,
58 trials/studies)
for this Drug
Key Diseases for which zafirlukast is
Relevant
-
Asthma (Bronchial Asthma)
:
36 outcomes 39 studies in 157 results
-
Contracture
:
7 outcomes 4 studies in 15 results
-
Chronic Obstructive Pulmonary Disease (COPD)
:
2 outcomes 3 studies in 5 results
-
Rhinitis
:
1 outcome 3 studies in 11 results
-
Bronchial Spasm
:
1 outcome 1 study in 3 results
Show All >>
Drugs Related to zafirlukast
-
zafirlukast (Accolate)
-
Leukotriene Receptors (Leukotriene Receptor)
-
fluticasone (Cutivate)
-
zileuton (Zyflo)
-
salmeterol (Serevent)
-
Loratadine (Alavert)
-
Adrenal Cortex Hormones (Corticosteroids)
-
montelukast (Singulair)
-
leukotriene D4 receptor (cysteinyl leukotriene receptor)
-
Leukotriene Antagonists (Leukotriene Receptor Antagonists)
Show All >>
Therapies Related to zafirlukast
-
Topical Administration
-
Drug Therapy (Chemotherapy)
-
Aftercare (After-Treatment)
-
Therapeutics
-
Off-Label Use
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.